NCT02926638 · Interventional trial
Lung-MAP: Rilotumumab and Erlotinib Hydrochloride or Erlotinib Hydrochloride Alone as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches
Overall registry status Terminated
Phase 2 · Phase 3
Conditions MET Positive, Recurrent Squamous Cell Lung Carcinoma, Stage IV Squamous Cell Lung Carcinoma AJCC v7
Delaware Valley sites
- Chester County Hospital · West Chester, PA · Chester County
- Fox Chase Cancer Center · Philadelphia, PA · Philadelphia County
- Virtua Memorial · Mount Holly, NJ · Burlington County
- Virtua Voorhees · Voorhees Township, NJ · Camden County
First posted
Registry updated
Added to the directory